NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Genre Technical Report ✖Remove constraint Genre: Technical Report Copyright Public domain ✖Remove constraint Copyright: Public domain

151. CMC postapproval manufacturing changes for specified biological products to be documented in annual reports

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, December 2021
Subject(s):
Annual Reports as Topic
Biological Products -- standards
Biological Products -- supply & distribution
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

153. CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):
Child Abuse -- legislation & jurisprudence
Elder Abuse -- legislation & jurisprudence
Government Regulation
Medicare -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

154. CMS could improve the data it uses to monitor antipsychotic drugs in nursing homes

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2021
Subject(s):
Antipsychotic Agents -- standards
Frail Elderly -- statistics & numerical data
Government Regulation
Nursing Homes -- legislation & jurisprudence
Vulnerable Populations -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

155. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018
Subject(s):
Durable Medical Equipment -- economics
Insurance, Health, Reimbursement
Medicare -- economics
Skilled Nursing Facilities
Home Care Services -- economics
Insurance Claim Review
Insurance Coverage
Medicaid -- economics
Nursing Homes
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

156. CMS has opportunities to strengthen states’ oversight of Medicaid Managed Care Plans’ reporting of medical loss ratios

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
Subject(s):
Government Regulation
Managed Care Programs -- organization & administration
Medicaid
State Health Planning and Development Agencies
United States
Centers for Medicare & Medicaid Services (U.S.)

158. CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Government Regulation
Medicaid -- economics
Naloxone -- supply & distribution
Opioid-Related Disorders -- economics
United States
United States. Department of Health and Human Services

159. CMS should take further action to address states with poor performance in conducting nursing home surveys

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, January 2022
Subject(s):
Government Regulation
Health Care Surveys -- standards
Nursing Homes -- legislation & jurisprudence
Public Reporting of Healthcare Data
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

160. CMS use of data on nursing home staffing: progress and opportunities to do more

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, March 2021
Subject(s):
Government Regulation
Health Workforce -- legislation & jurisprudence
Nursing Homes -- standards
United States
United States. Department of Health and Human Services
Centers for Medicare & Medicaid Services (U.S.)

161. CMS validated hospital inpatient quality reporting program data, but should use additional tools to identify gaming

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, April 2017
Subject(s):
Economics, Hospital
Insurance, Health, Reimbursement
Quality Indicators, Health Care
Reimbursement, Incentive
Cross Infection
Inpatients
Mandatory Reporting
Humans
United States
United States. Department of Health and Human Services.
Centers for Medicare & Medicaid Services (U.S.)

162. CMS’s encounter data lack essential information that Medicare Advantage organizations have the ability to collect

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, August 2020
Subject(s):
Data Management -- legislation & jurisprudence
Fraud -- prevention & control
Government Regulation
Medicare Part C -- organization & administration
Records -- statistics & numerical data
United States
United States. Department of Health and Human Services

163. COVID-19 Provider Relief Fund: HRSA continues to recover remaining payments due from providers : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
COVID-19
Disaster Planning -- economics
Disaster Planning -- organization & administration
Fraud -- prevention & control
Government Regulation
Health Personnel -- economics
Legislation, Medical
United States
United States. Health Resources and Services Administration

164. COVID-19 antivirals utilization: geographic and demographic patterns of treatment in 2022

Author(s):
Murphy, Stephen J. (Stephen James), author
Samson, Lok Wong, author
Sommers, Benjamin D., author
Publication:
Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 23, 2022
Subject(s):
Antiviral Agents -- therapeutic use
COVID-19 Drug Treatment
Drug Utilization -- statistics & numerical data
State Government
United States

167. COVID-19 contracting: Indian Health Service used flexibilities to meet increased medical supply needs : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, October 2021
Subject(s):
American Indians or Alaska Natives -- statistics & numerical data
COVID-19 -- ethnology
Equipment and Supplies -- supply & distribution
Government Regulation
United States
United States. Indian Health Service

169. COVID-19 in nursing homes: CMS needs to continue to strengthen oversight of infection prevention and control : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, September 2022
Subject(s):
COVID-19
Government Regulation
Infection Control -- legislation & jurisprudence
Legislation, Medical
Nursing Homes -- standards
United States
Centers for Medicare & Medicaid Services (U.S.)

170. COVID-19 in nursing homes: Experts identified actions aimed at improving infection prevention and control : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, March 2023
Subject(s):
COVID-19 -- prevention & control
Cross Infection -- prevention & control
Hand Hygiene -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Nursing Homes -- legislation & jurisprudence
United States

173. COVID-19 intensifies nursing home workforce challenges

Author(s):
Denny-Brown, Noelle, author
Stone, Denise, author
Hays, Burke, author
Gallagher, Dayna, author
Publication:
[Washington, D.C.] : United States Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, Office of Behavioral Health, Disability, and Aging Policy October 2020
Subject(s):
COVID-19
Health Workforce
Nursing Homes
Pandemics
United States

174. COVID-19 mortality rates across noncore, micropolitan, and metropolitan counties by community characteristics, December 2020-January 2021

Author(s):
Zahnd, Whitney E., author
Gadag, Khyathi, author
Ullrich, Fred, author
Mueller, Keith J., 1951- author
Publication:
Iowa City, IA : Rural Policy Research Institute, January 2023
Subject(s):
COVID-19 -- mortality
Local Government
Rural Population -- statistics & numerical data
Socioeconomic Factors
State Government
Urban Population -- statistics & numerical data
United States

176. COVID-19 pandemic: actions needed to improve federal oversight of assistance to individuals, communities, and the transportation industry : testimony before the Committee on Transportation and Infrastructure, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, July 29, 2021
Subject(s):
COVID-19 -- economics
Disasters -- economics
Government Regulation
United States

177. COVID-19 public health emergency: general considerations for pre-IND meeting requests for COVID-19 related drugs and biological products : guidance for industry and investigators

Publication:
[Silver Spring, MD] : Center for Drug Evaluation and Research, May 2020
Subject(s):
Biological Products
COVID-19 -- drug therapy
Drug Approval
Drug Industry
Drugs, Investigational
Drug Evaluation, Preclinical
Investigational New Drug Application
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

180. COVID-19 tests drove an increase in total Medicare Part B spending on lab tests in 2020, while use of non-COVID-19 tests decreased significantly

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, December 2021
Subject(s):
Clinical Laboratory Techniques -- economics
COVID-19 Testing -- economics
Government Regulation
Medicare Part B -- economics
United States
United States. Department of Health and Human Services

181. COVID-19 vaccination associated with reductions in COVID-19 mortality and morbidity in the United States, and an approach to valuing these benefits

Author(s):
Holtkamp, Nicholas, author
Kolbe, Allison, author
Beleche, Trinidad, author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, December 2021
Subject(s):
COVID-19 -- epidemiology
COVID-19 -- mortality
COVID-19 Vaccines -- economics
Hospitalization -- statistics & numerical data
Insurance Coverage
Morbidity
United States

182. COVID-19 vaccine hesitancy and reasons for hesitancy among essential and non-essential workers

Author(s):
Beleche, Trinidad, author
Ross, Tamia, author
Marus, Jessica, author
Karimi, Madjid, author
Grigorescu, Violanda, author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, March 2023
Subject(s):
Attitude of Health Personnel
COVID-19 Vaccines
Health Behavior
Health Personnel
Patient Acceptance of Health Care
Vaccination Hesitancy -- statistics & numerical data
United States

185. COVID-19: Current and future federal preparedness requires fixes to improve health data and address improper payments : report to congressional committees

Publication:
[Washington, DC] : United States Government Accountability Office, April 2022
Subject(s):
COVID-19 -- economics
Fraud -- legislation & jurisprudence
Government Regulation
Pandemics -- legislation & jurisprudence
Routinely Collected Health Data
United States

190. COVID-19: HHS and DOD transitioned vaccine responsibilities to HHS, but need to address outstanding issues : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, January 2022
Subject(s):
COVID-19 Vaccines -- supply & distribution
Government Regulation
Health Workforce -- legislation & jurisprudence
United States
United States. Department of Defense
United States. Department of Health and Human Services

191. COVID-19: HHS funds allocated to support disproportionately affected communities : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, January 2023
Subject(s):
COVID-19 -- economics
Disaster Planning -- legislation & jurisprudence
Government Regulation
Legislation, Medical
Pandemics -- economics
Arizona
Louisiana
Michigan
New Hampshire
Washington
United States. Department of Health and Human Services

194. COVID-19: Information on HHS's public education campaign : report to congressional committees

Publication:
Washington, DC : United States Government Accountability Office, March 2022
Subject(s):
Education, Public Health Professional
Financial Management -- organization & administration
Government Regulation
Health Promotion -- organization & administration
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
National Institutes of Health (U.S.)

195. COVID-19: Pandemic lessons highlight need for public health situational awareness network : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, June 2022
Subject(s):
Awareness
Civil Defense -- organization & administration
COVID-19
Government Regulation
Pandemics -- legislation & jurisprudence
United States
United States. Department of Health and Human Services

196. COVID-19: Selected states modified meal provision and other Older Americans Act services to prioritize safety : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, December 2021
Subject(s):
Food Services -- economics
Health Services for the Aged -- economics
Home Care Services -- organization & administration
Government Regulation
COVID-19
United States
United States.

198. COVID-19: USAID plans to share lessons learned from efforts to meet global vaccination goal : report to congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, September 2023
Subject(s):
COVID-19 Vaccines -- supply & distribution
Global Health
Government Regulation
Immunization Programs
International Cooperation
Legislation, Medical
United States
United States. Agency for International Development

199. COVID-19: VA should assess its oversight of infection prevention and control in community living centers : report to Congressional addressees

Publication:
Washington, DC : United States Government Accountability Office, July 2021
Subject(s):
Communicable Disease Control -- legislation & jurisprudence
COVID-19 -- economics
Government Regulation
Nursing Homes -- legislation & jurisprudence
United States
United States. Department of Veterans Affairs

Refine by:

more »

more »

more »

more »

Current results range from 1803 to 2024